![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears Cepheid’s On-Demand Coronavirus Test for Emergency Use
FDA Clears Cepheid’s On-Demand Coronavirus Test for Emergency Use
![COVID-19 TEST](https://www.fdanews.com/ext/resources/test/Device_Images6/COVID-19-test.gif?t=1584478370&width=430)
The FDA granted Cepheid an emergency use authorization for its Xpert Xpress SARS-CoV-2 point-of-care rapid diagnostic test.
The test, which was designed based on the company’s Flu/RSV testing cartridge product, can deliver results within hours and can be taken at patient care settings instead of relying on a lab to analyze samples.
The test runs on Cepheid’s GeneXpert system, a platform that doesn’t require special training. The company said the tests will be available by the end of the month.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct